Prevenar 20 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

Indications/Uses

Active immunisation for prevention of invasive disease, pneumonia, & acute otitis media caused by Strep pneumoniae in infants, childn & adolescents from 6 wk to <18 yr; prevention of invasive disease & pneumonia caused by Strep pneumoniae in individuals ≥18 yr.

Click to view Prevenar 20 detailed prescribing information

Dosage/Direction for Use

IM 0.5 mL (1 dose). Individual ≥18 yr, unvaccinated childn 2 to <5 yr 0.5 mL as single dose. Infant & childn 6 wk-15 mth, preterm infant <37 wk gestation 3 dose primary series: 1st dose given at 2 mth w/ at least 4-wk interval between doses, may be given as early as 6 wk. 4th (booster) dose given between 11-15 mth. Unvaccinated infant 7 to <12 mth 2 doses w/ at least 4-wk interval between doses, followed by 3rd dose in the 2nd yr. Unvaccinated childn 12 to <24 mth 2 doses w/ at least 8-wk interval between doses. Childn 15 mth to <5 yr previously fully vaccinated w/ Prevenar 13, childn & adolescent 5 yr to <18 yr regardless of prior Prevenar 13 0.5 mL as single dose, administer at least 8 wk after if w/ Prevenar 13.

Click to view Prevenar 20 detailed prescribing information

Overdosage

View Prevenar 20 overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to the vaccine or diphtheria toxoid.

Click to view Prevenar 20 detailed prescribing information

Special Precautions

Not to be inj intravascularly. Avoid inj into or near nerves & blood vessels. Not for protection against invasive disease, pneumonia or otitis media due to other microorganism. Postpone vaccination in individuals w/ acute severe febrile illness. Risk of hypersensitivity; bleeding in individuals w/ thrombocytopenia or bleeding disorder. Immunocompromised individuals, altered immunocompetence, impaired immune response. May cause hypersensitivity reactions due to polysorbate 80. May temporarily affect ability to drive & use machines. Pregnancy. Risk of apnoea in very premature infants (born ≤28 wk of gestation); consider resp monitoring for 48-72 hr after primary immunisation. Infants <6 wk.

Click to view Prevenar 20 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Prevenar 20 detailed prescribing information

Adverse Reactions

Decreased appetite; vaccination-site erythema, induration/swelling or pain/tenderness, vaccination site pain/tenderness causing limb movement limitation. Infants, childn & adolescents 6 wk to <18 yr: Irritability; drowsiness/increased sleep, restless/decreased sleep. Diarrhoea, vomiting; rash. Adults, childn & adolescents 5 to <18 yr: Headache; muscle & joint pain; fatigue. Adults, infants & childn 6 wk to <5 yr: Fever (pyrexia). Infants & childn 6 wk to <5 yr: Fever >38.9°C.

Click to view Prevenar 20 detailed prescribing information

Drug Interactions

Administer different inj vaccines at different vaccination sites. Not to be mixed w/ other vaccines/products in same syringe.

Click to view Prevenar 20 detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Prevenar 20 detailed prescribing information

Storage

View Prevenar 20 storage conditions for details to ensure optimal shelf-life.

Description

View Prevenar 20 description for details of the chemical structure and excipients (inactive components).

Action

View Prevenar 20 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07AL02 - pneumococcus, purified polysaccharides antigen conjugated ; Belongs to the class of pneumococcal bacterial vaccines.

Regulatory Classification

Presentation/Packing

Form

Prevenar 20 susp for inj (pre-filled syringe) 51 mcg/0.5 mL

Packing/Price

1's

Prevenar 20

vaccine, pneumococcal

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma